#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16296	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2018	800.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	956	C	880	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16296	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2018	800.6	0	HET	.	.	.	C207T	.	207	207	C	445	445	C	915	C,T	668,150	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29704	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3615	819.6	0	.	n	.	0	T695C	SNP	695	695	T	1092	1092	C	925	C	848	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29704	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3615	819.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2368	2368	C	924	C	823	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29704	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3615	819.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2442	2442	A	949	A	873	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29704	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3615	819.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2994	2994	C	919	C	848	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29704	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3615	819.6	0	HET	.	.	.	A1638G	.	1638	1638	A	2035	2035	A	982	A,G	643,242	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2104	folP	855	855	100.0	folP.l15.c4.ctg.1	1599	131.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1029	1031	AGC	223;220;221	A;G;C	198;195;193	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6388	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3442	185.1	1	SNP	p	S91F	1	.	.	271	273	TTC	643	645	TTC	213;213;218	T;T;C,A	193;193;195,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6388	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3442	185.1	1	SNP	p	D95G	1	.	.	283	285	GGC	655	657	GGC	212;207;205	G,A;G;C	196,1;191;190	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6388	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3442	185.1	1	SNP	p	G95N	0	.	.	283	285	GGC	655	657	GGC	212;207;205	G,A;G;C	196,1;191;190	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1756	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1333	131.2	1	SNP	p	G45D	0	.	.	133	135	GGC	458	460	GGC	215;217;215	G;G,T;C	193;192,1;191	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	864	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1081	79.6	0	.	n	.	0	A197.	DEL	197	197	A	681	681	A	214	A	192	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6576	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2903	225.6	1	SNP	p	D86N	0	.	.	256	258	GAC	588	590	GAC	277;280;279	G;A;C	247;251;254	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6576	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2903	225.6	1	SNP	p	R87I	0	.	.	259	261	CGT	591	593	CGT	279;277;276	C;G;T	255;249;249	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6576	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2903	225.6	1	SNP	p	R87W	0	.	.	259	261	CGT	591	593	CGT	279;277;276	C;G;T	255;249;249	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6576	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2903	225.6	1	SNP	p	S87R	1	.	.	259	261	CGT	591	593	CGT	279;277;276	C;G;T	255;249;249	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6576	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2903	225.6	1	SNP	p	S88P	0	.	.	262	264	TCC	594	596	TCC	276;277;275	T;C;C	249;250;248	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4690	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2483	187.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1491	1493	GGC	232;227;226	G;G;C	211;208;206	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	186.9	1	SNP	p	A311V	0	.	.	931	933	GCC	1271	1273	GCC	211;212;213	G;C,T;C,A	198;200,1;198,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	186.9	1	SNP	p	I312M	1	.	.	934	936	ATG	1274	1276	ATG	214;216;216	A;T;G,C	201;201;198,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	186.9	1	SNP	p	V316T	1	.	.	946	948	ACC	1286	1288	ACC	211;209;209	A,G;C,T;C,G	196,1;191,1;194,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	186.9	1	SNP	p	T316P	0	.	.	946	948	ACC	1286	1288	ACC	211;209;209	A,G;C,T;C,G	196,1;191,1;194,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	186.9	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1787	1789	ACC	277;277;282	A;C;C	241;247;251	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	186.9	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1841	1843	GCG	263;261;263	G;C;G	234;233;233	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	186.9	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1841	1843	GCG	263;261;263	G;C;G	234;233;233	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	186.9	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1964	1966	GGT	212;212;215	G;G;T	187;188;189	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	186.9	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1973	1975	AGC	208;205;204	A;G;C	179;180;179	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4490	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2391	186.9	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1991	1993	CCG	181;180;181	C,G;CG,CGGG;G	135,8;136,1;138	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6348	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3191	198.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1687	1689	CCG	222;220;223	C;C,G,A;G,C	199;202,1,1;202,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2558	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1600	158.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	453	453	C	184	C	163	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3184	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1547	203.4	0	.	p	.	0	I45V	NONSYN	133	135	ATT	528	530	GTT	310;308;306	G;T;T	276;272;274	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3184	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1547	203.4	1	SNP	p	G120K	1	.	.	358	360	AAG	753	755	AAG	262;260;258	A;A;G,C	238;238;235,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3184	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1547	203.4	1	SNP	p	N121D	0	.	.	361	363	AAC	756	758	AAC	261;261;263	A,G;A;C,A	239,1;239;236,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3184	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1547	203.4	1	SNP	p	A121N	1	.	.	361	363	AAC	756	758	AAC	261;261;263	A,G;A;C,A	239,1;239;236,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11488	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4926	232.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1240	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1003	122.9	1	SNP	p	V57M	1	.	.	169	171	ATG	545	547	ATG	244;243;243	A;T;G	221;219;219	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
